These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31589807)

  • 1. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
    Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
    HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    Darling KEA; Locatelli I; Benghalem N; Nadin I; Calmy A; Gutbrod K; Hauser C; Brugger P; Hasse B; Kovari H; Kunze U; Stoeckle M; Fux C; Rossi S; Di Benedetto C; Früh S; Schmid P; Tarr PE; Daeppen JB; Du Pasquier R; Cavassini M;
    PLoS One; 2021; 16(3):e0246579. PubMed ID: 33651794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
    Damas J; Ledergerber B; Nadin I; Tarr PE; Stoeckle M; Kunze U; Hauser C; Gutbrod K; Calmy A; Assal F; Schmid P; Hundsberger T; Di Benedetto C; Rossi S; Hasse B; Schlosser L; Du Pasquier R; Darling KEA; Cavassini M;
    AIDS; 2021 Dec; 35(15):2469-2480. PubMed ID: 34411034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
    Metral M; Nadin I; Locatelli I; Tarr PE; Calmy A; Kovari H; Brugger P; Cusini A; Gutbrod K; Schmid P; Schwind M; Kunze U; Di Benedetto C; Pignatti R; Du Pasquier R; Darling K; Cavassini M;
    HIV Med; 2020 May; 21(5):342-348. PubMed ID: 31883203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
    Santos GMA; Locatelli I; Métral M; Calmy A; Lecompte TD; Nadin I; Hauser C; Cusini A; Hasse B; Kovari H; Tarr P; Stoeckle M; Fux C; Di Benedetto C; Schmid P; Darling KEA; Du Pasquier R; Cavassini M;
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz277. PubMed ID: 31304188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
    Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
    J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
    Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
    Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
    Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
    Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.
    Makinson A; Dubois J; Eymard-Duvernay S; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; Gény C; Thouvenot E; Costagliola D; Ozguler A; Zins M; Simony M; Reynes J; Berr C
    Clin Infect Dis; 2020 Jun; 70(12):2641-2648. PubMed ID: 31755936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study.
    Trunfio M; Vuaran E; Vai D; Quarta C; Di Stefano A; Imperiale D; Cinnirella G; Bonora S; Di Perri G; Letendre SL; Calcagno A
    AIDS Behav; 2024 Nov; 28(11):3643-3654. PubMed ID: 39080201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
    Cysique LA; Brew BJ
    J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
    Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
    Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
    Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
    Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.